The discovery of fused oxadiazepines as gamma secretase modulators for treatment of Alzheimer’s disease-Reference-Cited by-同舟云学术

The discovery of fused oxadiazepines as gamma secretase modulators for treatment of Alzheimer’s disease

Published:2013-01 Issue:2 Volume:23 Page:466-471
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Li Hongmei,Qin Jun,Dhondi Pawan,Zhou Wei,Vicarel Monica,Bara Thomas,Cole David,Josien Hubert,Pissarnitski Dmitri,Zhu Zhaoning,Palani Anandan,Aslanian Robert,Clader John,Czarniecki Michael,Greenlee William,Cohen-Williams Mary,Hyde Lynn,Song Lixin,Zhang Lili,Chu Inhou,Huang Xianhai

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference34 articles.

1. World Alzheimer Report 2010: The Global Economic Impact of Dementia;Wimo,2010

2. Current approaches in the treatment of Alzheimer's disease

3. Review: Therapy for Alzheimer's disease: how effective are current treatments?

4. Tau phosphorylation and aggregation in Alzheimer's disease pathology

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Insight into Rational Drug Design: The Development of In-House Azole Compounds with Antimicrobial Activity;Antibiotics;2024-08-13

2. 4-Vinylbenzodioxinones as a new type of precursor for palladium-catalyzed (4+3) cycloaddition of azomethine imines;Chemical Communications;2024

3. Unusual Formation of 1,2,4-Oxadiazine Core in Reaction of Amidoximes with Maleic or Fumaric Esters;Molecules;2022-11-03

4. Finding Cures for Alzheimer's Disease;Contemporary Accounts in Drug Discovery and Development;2022-03-07

5. Characterizing the Chemical Space of γ-Secretase Inhibitors and Modulators;ACS Chemical Neuroscience;2021-07-22